FINOTTI, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 3.072
AS - Asia 1.376
EU - Europa 924
SA - Sud America 269
AF - Africa 245
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 16
Totale 5.929
Nazione #
US - Stati Uniti d'America 2.912
SG - Singapore 574
CN - Cina 307
DE - Germania 276
BR - Brasile 172
HK - Hong Kong 123
FI - Finlandia 98
VN - Vietnam 91
UA - Ucraina 72
SE - Svezia 58
IT - Italia 52
GB - Regno Unito 51
FR - Francia 31
PL - Polonia 30
RU - Federazione Russa 25
NL - Olanda 24
AR - Argentina 20
PK - Pakistan 19
EC - Ecuador 16
BE - Belgio 15
MX - Messico 15
PS - Palestinian Territory 15
TR - Turchia 15
CA - Canada 14
IN - India 13
GM - Gambi 12
PR - Porto Rico 12
HU - Ungheria 11
JM - Giamaica 11
UY - Uruguay 11
AT - Austria 10
BB - Barbados 10
LA - Repubblica Popolare Democratica del Laos 10
NC - Nuova Caledonia 10
RS - Serbia 10
SA - Arabia Saudita 10
SN - Senegal 10
UZ - Uzbekistan 10
YE - Yemen 10
AE - Emirati Arabi Uniti 9
CL - Cile 9
ES - Italia 9
ID - Indonesia 9
IE - Irlanda 9
IR - Iran 9
JO - Giordania 9
JP - Giappone 9
KE - Kenya 9
KG - Kirghizistan 9
KZ - Kazakistan 9
MA - Marocco 9
MK - Macedonia 9
PT - Portogallo 9
SI - Slovenia 9
TN - Tunisia 9
XK - ???statistics.table.value.countryCode.XK??? 9
ZA - Sudafrica 9
AF - Afghanistan, Repubblica islamica di 8
AL - Albania 8
AM - Armenia 8
BZ - Belize 8
CU - Cuba 8
CV - Capo Verde 8
EE - Estonia 8
GF - Guiana Francese 8
GR - Grecia 8
HR - Croazia 8
KH - Cambogia 8
MY - Malesia 8
PH - Filippine 8
PY - Paraguay 8
RW - Ruanda 8
UG - Uganda 8
BD - Bangladesh 7
BG - Bulgaria 7
CH - Svizzera 7
CI - Costa d'Avorio 7
CO - Colombia 7
CR - Costa Rica 7
CW - ???statistics.table.value.countryCode.CW??? 7
DO - Repubblica Dominicana 7
GE - Georgia 7
GH - Ghana 7
LT - Lituania 7
MW - Malawi 7
MZ - Mozambico 7
NI - Nicaragua 7
RO - Romania 7
TH - Thailandia 7
VC - Saint Vincent e Grenadine 7
VE - Venezuela 7
YT - Mayotte 7
AD - Andorra 6
AO - Angola 6
AZ - Azerbaigian 6
CM - Camerun 6
DZ - Algeria 6
GN - Guinea 6
GP - Guadalupe 6
HT - Haiti 6
Totale 5.656
Città #
Singapore 325
Ashburn 284
Fairfield 274
Jacksonville 238
Chandler 224
Woodbridge 217
Ann Arbor 198
Houston 190
Wilmington 132
Hong Kong 117
Cambridge 115
Seattle 99
Beijing 85
San Jose 84
Princeton 77
Boardman 66
Helsinki 50
Santa Clara 50
Nanjing 40
Roxbury 32
San Diego 32
Des Moines 30
Medford 29
Nürnberg 25
Los Angeles 24
Dong Ket 22
Padova 22
Ho Chi Minh City 20
Shenyang 20
Hanoi 19
Bytom 17
São Paulo 17
Guangzhou 15
Chicago 14
Hebei 13
Boston 12
New York 12
Buffalo 11
Dakar 10
Kingston 10
Noumea 10
Tashkent 10
Bridgetown 9
Norwalk 9
Redwood City 9
Stockholm 9
Vientiane 9
Amman 8
Atlanta 8
Bishkek 8
Dublin 8
Kampala 8
Kigali 8
Montevideo 8
Phnom Penh 8
Toronto 8
Vienna 8
Warsaw 8
Yerevan 8
Accra 7
Athens 7
Belize City 7
Havana 7
Jinan 7
Kingstown 7
Managua 7
Nairobi 7
San José 7
Skopje 7
Abidjan 6
Abu Dhabi 6
Andorra la Vella 6
Bamako 6
Banjul 6
Brooklyn 6
Conakry 6
Dushanbe 6
Guayaquil 6
Kuala Lumpur 6
Lilongwe 6
Orem 6
Papeete 6
Praia 6
Reykjavik 6
San Juan 6
Sanaa 6
Tehran 6
Tokyo 6
Willemstad 6
Zagreb 6
Antakya 5
Antananarivo 5
Baku 5
Bangkok 5
Brasília 5
Brazzaville 5
Brussels 5
Da Nang 5
Dallas 5
Dar es Salaam 5
Totale 3.678
Nome #
Identification and purification from the plasma of Type 1 diabetic subjects of a proteolytically active Grp94Evidence that Grp94 is entirely responsible for plasma proteolytic activity. 275
Grp94 in complexes with IgG is a soluble diagnostic marker of gastrointestinal tumors and displays immune-stimulating activity on peripheral blood immune cells 220
Crucial role of HSP90 in the Akt-dependent promotion of angiogenic-like effect of Glucose-regulated protein94 (Grp94)-IgG complexes 217
Angiogenic transforming capacity of IgG purified from plasma of type 1 diabetic patients 216
Human IgGs induce synthesis and secretion of IgGs and neonatal Fc receptor in human umbilical vein endothelial cells 195
Structural Insights into Complexes of Glucose-Regulated Protein94 (Grp94) with Human Immunoglobulin G. Relevance for Grp94-IgG Complexes that Form In Vivo in Pathological Conditions 194
Proteomic investigation on Grp94-IgG complexes circulating in plasma of type 1 diabetic subjects 194
Characterization of immune complexes of idiotypic catalytic and anti-idiotypic inhibitory antibodies in plasma of type 1 diabetic subjects 190
Alteration of plasma proteinase-antiproteinase system in type 1 diabetic patients. Influence of sex and relationship with metabolic control. 185
Stable complexes formed by Grp94 with human IgG promoting angiogenic differentiation of HUVECs by a cytokine-like mechanism. 179
Long-term blood glucose control and diabetic retinopathy. 178
Comment on: Antibodies to the endoplasmic reticulum-resident chaperones calnexin, Bip and Grp94 in patients with rheumatoid arthritis and systemic lupus erythematosus 178
Effects of Glucose-regulated protein94 (Grp94) on Ig secretion from human blood mononuclear cells 154
The role played by serine proteases in the development and worsening of vascular complications in Type 1 diabetes mellitus. 148
Albumin contamination of a purified human alpha1-antitrypsin preparation does not affect either structural conformation or the electrophoretic mobility of the inhibitor. 135
Mechanism of Na+/K(+)-ATPase activation by trypsin and kallikrein. 128
Inhibition of immunoglobulin secretion from peripheral blood mononuclear cells by glucose-regulated protein94 (Grp94) inallergic subjects 126
Biphasic pattern of heparin-induced oxidative degradation of trypsin in the presence of glucose. 122
Reduction of erythrocyte (Na+-K+)ATPase activity in type 1 (insulin-dependent) diabetic subjects and its activation by homologous plasma. 120
A heat shock protein70 fusion protein with alpha(1)-antitrypsin in plasma of Type 1 diabetic subjects 118
Effects of Glucose-Regulated Protein94 (GRP94) and complexes of GRP94 with IgG on cells of the innate and adaptive immunity (SIF award for the best oral communication) 118
Complessi di Grp94 ed Immunoglobuline G umane 114
[Effects of digoxin on plasma renin activity in man. II]. 114
Immune complexes of glucose-regulated protein94 (Grp94) with IgG, present in the plasma of type 1 diabetic subjects, show strong angiogenic-transforming capacity on HUVECs 112
Separation by heparin-affinity chromatography of catalytically active and inactive forms of trypsin which retain the (Na-K)ATPase stimulating property. 112
Complexes of Grp94 with human Immunoglobulin G 111
Immune complexes of Glucose-regulated protein94 (Grp94) with IgG are present in the plasma of Type 1 diabetic subjects and show strong angiogenic-transforming capacity on HUVECs (oral communication) 110
The oxidative mechanism of heparin interferes with radical production by glucose and reduces the degree of glycooxidative modifications on human serum albumin 110
Differential effects of heparin and glucose on structural conformation of human alpha1-antitrypsin: evidence for a heparin-induced cleaved form of the inhibitor. 106
Kinetic studies with competitive inhibitors indicate a sequential mechanism for dopamine beta-hydroxylase. 104
Differential Mechanism for structural and functional alterations of trypsin by heparin, evidence for a speific radical-generating mechanism at low heparin concentrations. 100
Induction of angiogenesis by the heat shock protein Glucose-regulated protein94 (Grp94) mediated by a cytokine-like mechanism. 100
Effects of intact and reduced reducing termini in heparin on structural and functional modifications of trypsin. 97
Effects of digoxin on plasma renin activity in hypertensive patients. 92
Heparin-induced structural modifications and oxidative cleavage of human serum albumin in the absence and presence of glucose. 91
Heparin-induced structural and functional alterations of bovine trypsin. 91
Inhibition of dopamine beta-hydroxylase by captopril. 85
Both a serine-like protease and a protease inhibitory activity are present in circulating immune complexes in type 1 diabetes mellitus. 84
Role of reducing terminals in unfractionated and low-molecular-mass heparins in causing free radical generation and loss of structure and activity of tripsin. 81
New insights into the molecular mechanism of heparin-protein interactions. Revisiting the role and function of heparin in the light of its oxidative property 79
Spin-trapping agent alpha-phenyl N-tert-butylnitrone binds to trypsin and enhances heparin-induced inhibition of amidolytic activity and structural degradation of the enzyme. 72
Heparin effects on glycated human serum albumin 72
Sex and parental hypertension as predictors of worsened red blood cell membrane enzyme activities in type 1 insulin-dependent diabetic subjects. 66
IDENTIFICAZIONE DI UNA " GLUCOSE-REGULATED PROTEIN" 94 GRP94 MODIFICATA E USO DELLA STESSA E DI ANTICORPI ANTI-GRP94 NELLE COMPLICANZE VASCOLARI DEL DIABETE 64
Inhibition of enzymes and enzyme by phenothiazines and their radicals. In: Phenothiazienes and 1,4-benzothiazines 64
Spin-trapping agent alpha-phenyl N-Tert-butylnitrone as inhibitor of trypsin and enhancer of the oxidative degradation of the enzyme by heparin 62
Purification of proteinase-like and Na+/K(+)-ATPase stimulating substance from plasma of insulin-dependent diabetics and its identification as alpha 1-antitrypsin 54
Totale 5.937
Categoria #
all - tutte 18.339
article - articoli 14.983
book - libri 223
conference - conferenze 0
curatela - curatele 0
other - altro 191
patent - brevetti 653
selected - selezionate 0
volume - volumi 0
Totale 34.389


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021232 0 0 0 0 0 0 9 42 58 22 60 41
2021/2022474 4 64 44 42 21 38 16 47 26 9 45 118
2022/2023454 90 63 12 42 68 76 0 31 41 1 25 5
2023/2024224 17 34 29 19 31 15 18 5 2 3 26 25
2024/2025851 0 37 35 51 138 25 36 63 84 20 150 212
2025/20261.974 128 278 387 528 361 159 133 0 0 0 0 0
Totale 5.937